These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27497629)

  • 41. Noninterventional treatment of selected head and neck lymphatic malformations.
    Dasgupta R; Adams D; Elluru R; Wentzel MS; Azizkhan RG
    J Pediatr Surg; 2008 May; 43(5):869-73. PubMed ID: 18485956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment guidelines of lymphatic malformations of the head and neck.
    Zhou Q; Zheng JW; Mai HM; Luo QF; Fan XD; Su LX; Wang YA; Qin ZP
    Oral Oncol; 2011 Dec; 47(12):1105-9. PubMed ID: 21906990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations.
    Balakrishnan K; Menezes MD; Chen BS; Magit AE; Perkins JA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):41-5. PubMed ID: 24288004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children.
    Emran MA; Dubois J; Laberge L; Al-Jazaeri A; Bütter A; Yazbeck S
    J Pediatr Surg; 2006 May; 41(5):975-9. PubMed ID: 16677896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sclerotherapy for congenital lesions in the head and neck.
    Kim KH; Sung MW; Roh JL; Han MH
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):307-16. PubMed ID: 15365552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intralesional bleomycin sclerotherapy in childhood lymphangioma.
    Erikçi V; Hoşgör M; Yıldız M; Örnek Y; Aksoy N; Okur Ö; Demircan Y; Genişol İ
    Turk J Pediatr; 2013; 55(4):396-400. PubMed ID: 24292033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.
    Bai Y; Jia J; Huang XX; Alsharif MJ; Zhao JH; Zhao YF
    J Oral Maxillofac Surg; 2009 Feb; 67(2):251-6. PubMed ID: 19138596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.
    Sung MW; Lee DW; Kim DY; Lee SJ; Hwang CH; Park SW; Kim KH
    Laryngoscope; 2001 Aug; 111(8):1430-3. PubMed ID: 11568580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic strategy for cervicofacial lymphangioma in children].
    Roelly P; Garabedian EN; Attal P; Denoyelle F; Tashjian G
    Ann Otolaryngol Chir Cervicofac; 1991; 108(4):227-30. PubMed ID: 1854148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cystic cervicofacial lymphangioma].
    Ennouri A; Hajri H; Ben Rhouma S; Ben Abdallah N; Miladi M; Bouzouita KA; Marrekchi H
    Rev Stomatol Chir Maxillofac; 1990; 91(5):385-9. PubMed ID: 2218389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphographic-Like Technique for the Treatment of Microcystic Lymphatic Malformation Components of <3 mm.
    Da Ros V; Iacobucci M; Puccinelli F; Spelle L; Saliou G
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):350-354. PubMed ID: 29191875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-Year Outcomes of Transcutaneous Non-Image Guided Bleomycin Sclerotherapy in Conjunctival Lymphatic Malformations: A Protocol-Based Management in 16 Eyes.
    Dave TV; Walvekar P
    Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):64-71. PubMed ID: 35829652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Management of Giant Cerviofacial Lymphatic Malformations in Children.
    Li W; Xu H; Zhao L; Li X
    J Craniofac Surg; 2019 Sep; 30(6):e553-e555. PubMed ID: 30985347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sclerosing treatment of lymphangiomas with OK-432.
    Luzzatto C; Midrio P; Tchaprassian Z; Guglielmi M
    Arch Dis Child; 2000 Apr; 82(4):316-8. PubMed ID: 10735841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.
    Shiels WE; Kenney BD; Caniano DA; Besner GE
    J Pediatr Surg; 2008 Jan; 43(1):136-9; discussion 140. PubMed ID: 18206471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.
    Zhong PQ; Zhi FX; Li R; Xue JL; Shu GY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):139-44. PubMed ID: 9720086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphatic malformations of the head and neck. A proposal for staging.
    de Serres LM; Sie KC; Richardson MA
    Arch Otolaryngol Head Neck Surg; 1995 May; 121(5):577-82. PubMed ID: 7727093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphatic malformation: predictive factors for recurrence.
    Fliegelman LJ; Friedland D; Brandwein M; Rothschild M
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):706-10. PubMed ID: 11112962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.